CoChat
Sign Up
Cited by 80

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells

Oh, J.-M., Kim, S.-H., Cho, E.-A., Song, Y.-S., Kim, W.-H., Juhnn, Y.-S.·2010·Carcinogenesis
DOI 10.1093/carcin/bgp318
Open this paper in CoChat — free account

Abstract

To investigate the mechanism by which the human papillomavirus (HPV) E5 protein contributes to the carcinogenesis of uterine cervical cancer, we studied the effect of HPV E5 on apoptosis of cervical cancer cells and its underlying mechanism. Expression of HPV16 E5 protein inhibited hydrogen peroxide-induced apoptosis in C-33A cervical cancer cells. E5 decreased the expression of Bax protein, and exogenous expression of Bax abolished the anti-apoptotic effect of E5. Knockdown of E5 by small interfering RNA sensitized CaSki cervical cancer cells to hydrogen peroxide-induced apoptosis with concurrent increase in Bax expression. Transient expression of E5 significantly increased the degradation rate of Bax protein by inducing the ubiquitination. The E5-induced decrease in Bax expression was inhibited by a cyclooxygenase-2 (COX-2) inhibitor, prostaglandin E2 (PGE(2)) receptor antagonists and cyclic adenosine monophosphate-dependent protein kinase (PKA) inhibitor. Treatment with PGE(2) decreased the expression of Bax and inhibited hydrogen peroxide-induced apoptosis of C-33A cells. We concluded that HPV16 E5 protein inhibits hydrogen peroxide-induced apoptosis of cervical cancer cells by stimulating the ubiquitin-proteasome-mediated degradation of Bax protein, and the pathway involves COX-2, PGE(2) and PKA. This finding suggests the possibility that HPV 16 E5 protein contributes to cervical carcinogenesis by inhibiting apoptosis of transformed cervical epithelial cells.

Overview

Integrity signals

Registry

Crossref · 10.1093/carcin/bgp318

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 45

  1. 2002, NAT REV, 2, 342, 10.1038/nrc798 · DOI
  2. 2007, NAT REV, 7, 11, 10.1038/nrc2050 · DOI
  3. Scheffner, 1990, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8 · DOI · Paper page
  4. M nger, 2001, Oncogene, 20, 7888, 10.1038/sj.onc.1204860 · DOI
  5. Conrad, 1993, Journal of Virology, 67, 6170, 10.1128/JVI.67.10.6170-6178.1993 · DOI
  6. Pim, 1992, Oncogene, 7, 27
  7. Straight, 1993, Journal of Virology, 67, 4521, 10.1128/JVI.67.8.4521-4532.1993 · DOI · Paper page
  8. 1996, 223, 251, 10.1006/viro.1996.0475 · DOI · Paper page
  9. Leechanachai, 1992, Oncogene, 7, 19
  10. Genther Williams, 2005, Cancer Research, 65, 6534, 10.1158/0008-5472.CAN-05-0083 · DOI · Paper page
  11. Maufort, 2007, Cancer Research, 67, 6106, 10.1158/0008-5472.CAN-07-0921 · DOI
  12. Tomakidi, 2000, European journal of cell biology, 79, 407, 10.1078/0171-9335-00060 · DOI · Paper page
  13. Mates, 2008, Archives of toxicology, 82, 273, 10.1007/s00204-008-0304-z · DOI
  14. Kabsch, 2002, Journal of Virology, 76, 12162, 10.1128/JVI.76.23.12162-12172.2002 · DOI
  15. Kabsch, 2004, Intervirology, 47, 48, 10.1159/000076642 · DOI · Paper page
  16. Zhang, 2002, Journal of Virology, 76, 220, 10.1128/JVI.76.1.220-231.2002 · DOI · Paper page
  17. Yee, 1985, American Journal Of Pathology, 119, 361
  18. Siadat-Pajouh, 1994, Journal of Histochemistry and Cytochemistry, 42, 1503, 10.1177/42.11.7930533 · DOI
  19. 2009, Carcinogenesis, 30, 141, 10.1093/carcin/bgn236 · DOI
  20. Rhim, 1985, Science, 227, 1250, 10.1126/science.2579430 · DOI
  21. 2000, PNAS, 97, 3850, 10.1073/pnas.070047997 · DOI
  22. Choi, 2001, Journal of neurochemistry, 77, 1531, 10.1046/j.1471-4159.2001.00368.x · DOI
  23. Gorman, 1997, FEBS Letters, 404, 27, 10.1016/S0014-5793(97)00069-0 · DOI
  24. Pelicano, 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 7, 97, 10.1016/j.drup.2004.01.004 · DOI
  25. Kabsch, 2002, Oncogene, 21, 947, 10.1038/sj.onc.1205147 · DOI
  26. Youle, 2008, Nature reviews. Molecular cell biology, 9, 47, 10.1038/nrm2308 · DOI
  27. Oltvai, 1993, Cell, 74, 609, 10.1016/0092-8674(93)90509-O · DOI · Paper page
  28. Newmeyer, 2003, Cell, 112, 481, 10.1016/S0092-8674(03)00116-8 · DOI
  29. Rampino, 1997, Science, 275, 967, 10.1126/science.275.5302.967 · DOI
  30. Miquel, 2005, American Journal of Clinical Pathology, 123, 562, 10.1309/JQ2X3RV3L8F9TGYW · DOI
  31. Harima, 1998, Journal of cancer research and clinical oncology, 124, 503, 10.1007/s004320050206 · DOI
  32. Sultana, 2003, Annals of Oncology, 14, 214, 10.1093/annonc/mdg071 · DOI
  33. Krajewski, 1995, Cancer Research, 55, 4471
  34. Fecker, 2006, Journal of Investigative Dermatology, 126, 1366, 10.1038/sj.jid.5700192 · DOI
  35. Ciechanover, 1994, Cell, 79, 13, 10.1016/0092-8674(94)90396-4 · DOI
  36. Zhang, 2004, Oncogene, 23, 2009, 10.1038/sj.onc.1207373 · DOI
  37. Yu, 2008, Biochemical and biophysical research communications, 371, 10, 10.1016/j.bbrc.2008.03.122 · DOI
  38. 2008, Blood, 111, 2790, 10.1182/blood-2007-10-110460 · DOI
  39. 2008, Blood, 111, 2797, 10.1182/blood-2007-08-110445 · DOI
  40. Vogt, 2006, Oncogene, 25, 4009, 10.1038/sj.onc.1209429 · DOI · Paper page
  41. Kim, 2006, Pharmacological research : the official journal of the Italian Pharmacological Society, 54, 261, 10.1016/j.phrs.2006.05.006 · DOI
  42. Cho, 2002, Clinical Cancer Research, 8, 607
  43. Martin, 2006, Biochemical Society Transactions, 34, 480, 10.1042/BST0340480 · DOI
  44. Daniel, 1998, Annual review of nutrition, 18, 353, 10.1146/annurev.nutr.18.1.353 · DOI
  45. Oetke, 2000, Archives of virology, 145, 2183, 10.1007/s007050070048 · DOI

Cited by

See all 80

Metadata

Authors
Oh, J.-M., Kim, S.-H., Cho, E.-A., Song, Y.-S., Kim, W.-H., & Juhnn, Y.-S.
Venue
Carcinogenesis
Publisher
Oxford University Press (OUP)
Published
2009-12-16
Volume
31
Issue
3
Pages
402-410
ISSN
  • 0143-3334
  • 1460-2180
DOI
10.1093/carcin/bgp318
Cited by
80
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells. https://app.cochat.ai/papers/10.1093/carcin/bgp318
The paper
Oh, J.-M., Kim, S.-H., Cho, E.-A., Song, Y.-S., Kim, W.-H., & Juhnn, Y.-S. (2010). Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells. Carcinogenesis. https://doi.org/10.1093/carcin/bgp318